Prilosec OTC Name Will Create Consumer Confusion With Rx Drugs – Petition
This article was originally published in The Tan Sheet
Executive Summary
FDA should require that Prilosec OTC be sold under a different brand name to "reduce the risk of consumer confusion" resulting from extensive direct-to-consumer advertising for the Rx version of the drug, an Aug. 12 citizen petition says
You may also be interested in...
Prilosec OTC Forced Name Change Rejected As FDA Clears Pending Petitions
A lack of data supporting consumer confusion claims between nonprescription Prilosec and the eponymous Rx version is cited by FDA in a letter denying a citizen petition. The petitioner sought an agency-mandated name change
Prilosec OTC Forced Name Change Rejected As FDA Clears Pending Petitions
A lack of data supporting consumer confusion claims between nonprescription Prilosec and the eponymous Rx version is cited by FDA in a letter denying a citizen petition. The petitioner sought an agency-mandated name change
Prilosec OTC Forced Name Change Rejected As FDA Clears Pending Petitions
A lack of data supporting consumer confusion claims between nonprescription Prilosec and the eponymous Rx version is cited by FDA in a letter denying a citizen petition. The petitioner sought an agency-mandated name change